| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/30/2023 | 22.01% | RBC Capital | $23 → $24 | Maintains | Sector Perform |
| 10/30/2023 | 47.43% | Raymond James | $28 → $29 | Maintains | Outperform |
| 10/17/2023 | 27.1% | Morgan Stanley | $24 → $25 | Maintains | Overweight |
| 10/03/2023 | 6.76% | Wells Fargo | $20 → $21 | Maintains | Equal-Weight |
| 08/09/2023 | -8.49% | Goldman Sachs | $16 → $18 | Maintains | Sell |
| 08/01/2023 | 22.01% | Morgan Stanley | $22 → $24 | Maintains | Overweight |
| 08/01/2023 | 32.18% | Citigroup | $21 → $26 | Maintains | Buy |
| 07/31/2023 | 1.68% | Piper Sandler | $21 → $20 | Maintains | Neutral |
| 07/31/2023 | 22.01% | Morgan Stanley | $22 → $24 | Maintains | Overweight |
| 07/31/2023 | 42.35% | Benchmark | → $28 | Reiterates | Buy → Buy |
| 07/31/2023 | 32.18% | Citigroup | $21 → $26 | Maintains | Buy |
| 07/31/2023 | 42.35% | Raymond James | $27 → $28 | Maintains | Outperform |
| 07/28/2023 | 1.68% | Wells Fargo | $18 → $20 | Maintains | Equal-Weight |
| 07/18/2023 | 6.76% | Citigroup | $22 → $21 | Maintains | Buy |
| 07/17/2023 | 11.85% | Morgan Stanley | $22 → $22 | Reiterates | Overweight → Overweight |
| 07/14/2023 | 1.68% | Capital One | → $20 | Initiates Coverage On | → Equal-Weight |
| 07/14/2023 | 37.26% | Raymond James | $29 → $27 | Maintains | Outperform |
| 06/13/2023 | -18.66% | Goldman Sachs | $17 → $16 | Maintains | Sell |
| 06/02/2023 | 11.85% | Citigroup | $23 → $22 | Maintains | Buy |
| 05/01/2023 | 6.76% | Piper Sandler | $22 → $21 | Maintains | Neutral |
| 05/01/2023 | 1.68% | Barclays | $25 → $20 | Maintains | Equal-Weight |
| 04/18/2023 | 11.85% | Morgan Stanley | $24 → $22 | Maintains | Overweight |
| 04/05/2023 | 16.93% | Citigroup | $25 → $23 | Maintains | Buy |
| 02/08/2023 | 37.26% | Cowen & Co. | $26 → $27 | Maintains | Outperform |
| 02/08/2023 | 47.43% | Susquehanna | $26 → $29 | Maintains | Positive |
| 02/08/2023 | 11.85% | Piper Sandler | → $22 | Maintains | Neutral |
| 02/08/2023 | 37.26% | RBC Capital | → $27 | Reiterates | → Sector Perform |
| 01/19/2023 | 42.35% | Benchmark | → $28 | Initiates Coverage On | → Buy |
| 01/04/2023 | 22.01% | Morgan Stanley | $21 → $24 | Upgrades | Equal-Weight → Overweight |
| 11/07/2022 | 27.1% | Wells Fargo | $16 → $25 | Upgrades | Underweight → Equal-Weight |
| 11/01/2022 | 27.1% | Barclays | $22 → $25 | Maintains | Equal-Weight |
| 10/31/2022 | 6.76% | Morgan Stanley | $20 → $21 | Maintains | Equal-Weight |
| 10/13/2022 | 1.68% | Morgan Stanley | $19 → $20 | Maintains | Equal-Weight |
| 10/12/2022 | 27.1% | Citigroup | → $25 | Upgrades | Neutral → Buy |
| 09/30/2022 | -3.41% | B of A Securities | → $19 | Upgrades | Neutral → Buy |
| 08/25/2022 | — | Benchmark | Initiates Coverage On | → Hold | |
| 07/29/2022 | -3.41% | Morgan Stanley | $18 → $19 | Maintains | Equal-Weight |
| 07/29/2022 | — | B of A Securities | Upgrades | Underperform → Neutral | |
| 07/13/2022 | -8.49% | Morgan Stanley | $20 → $18 | Maintains | Equal-Weight |
| 07/13/2022 | -18.66% | Goldman Sachs | $18 → $16 | Maintains | Sell |
| 06/08/2022 | 11.85% | Barclays | $20 → $22 | Maintains | Equal-Weight |
| 05/02/2022 | 1.68% | Barclays | $15 → $20 | Maintains | Equal-Weight |
| 04/11/2022 | 1.68% | Morgan Stanley | $17 → $20 | Maintains | Equal-Weight |
| 03/31/2022 | -18.66% | Wells Fargo | $14 → $16 | Maintains | Underweight |
| 02/23/2022 | -18.66% | Goldman Sachs | → $16 | Downgrades | Neutral → Sell |
| 02/07/2022 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 12/14/2021 | -13.57% | JP Morgan | → $17 | Upgrades | Neutral → Overweight |
| 10/11/2021 | -13.57% | Morgan Stanley | $18 → $17 | Maintains | Equal-Weight |
| 09/09/2021 | -23.74% | RBC Capital | → $15 | Assumes | → Sector Perform |
| 07/19/2021 | -23.74% | BMO Capital | $14 → $15 | Upgrades | Underperform → Market Perform |
| 07/16/2021 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 07/09/2021 | -8.49% | Morgan Stanley | $13 → $18 | Upgrades | Underweight → Equal-Weight |
| 05/13/2021 | -8.49% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
| 04/29/2021 | -33.91% | Morgan Stanley | $12 → $13 | Maintains | Underweight |
| 01/21/2021 | -13.57% | Wells Fargo | $13.5 → $17 | Upgrades | Equal-Weight → Overweight |
| 01/12/2021 | -8.49% | Citigroup | $15 → $18 | Upgrades | Neutral → Buy |
| 01/06/2021 | — | B of A Securities | Upgrades | Underperform → Neutral | |
| 11/10/2020 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 10/28/2020 | -38.99% | Wells Fargo | $13.5 → $12 | Maintains | Equal-Weight |
| 10/28/2020 | -23.74% | Stifel | $16 → $15 | Maintains | Buy |
| 10/28/2020 | -23.74% | Credit Suisse | $14 → $15 | Reiterates | → Outperform |
| 10/02/2020 | -54.25% | BMO Capital | → $9 | Initiates Coverage On | → Underperform |
| 07/29/2020 | -23.74% | JP Morgan | $14 → $15 | Maintains | Neutral |
| 07/29/2020 | -42.55% | Piper Sandler | $11.4 → $11.3 | Maintains | Neutral |
| 07/09/2020 | -33.91% | Morgan Stanley | $12 → $13 | Maintains | Equal-Weight |
| 05/26/2020 | -44.08% | UBS | $10 → $11 | Maintains | Neutral |
| 05/14/2020 | -59.33% | Barclays | → $8 | Downgrades | Overweight → Equal-Weight |
| 04/29/2020 | -18.66% | Stifel | $18 → $16 | Maintains | Buy |
| 04/29/2020 | -54.25% | Piper Sandler | $11 → $9 | Maintains | Neutral |
| 04/29/2020 | -28.83% | Raymond James | $11 → $14 | Maintains | Outperform |
| 04/14/2020 | -13.57% | Cowen & Co. | → $17 | Upgrades | Market Perform → Outperform |
| 04/09/2020 | -49.16% | UBS | $21 → $10 | Maintains | Neutral |
| 04/01/2020 | -8.49% | Stifel | $17 → $18 | Maintains | Buy |
| 03/27/2020 | -33.91% | RF Lafferty | $27 → $13 | Maintains | Buy |
| 03/27/2020 | -44.08% | Piper Sandler | → $11 | Downgrades | Overweight → Neutral |
| 03/20/2020 | -33.91% | Credit Suisse | $25 → $13 | Upgrades | Neutral → Outperform |
| 03/19/2020 | -28.83% | Barclays | $25 → $14 | Upgrades | Equal-Weight → Overweight |
| 03/10/2020 | -13.57% | Stifel | $28 → $17 | Maintains | Buy |
| 03/03/2020 | 6.76% | UBS | $25 → $21 | Maintains | Neutral |
| 02/19/2020 | — | Argus Research | Downgrades | Buy → Hold | |
| 02/10/2020 | 32.18% | Wells Fargo | $25 → $26 | Maintains | Equal-Weight |
| 02/10/2020 | 52.52% | Susquehanna | $28 → $30 | Maintains | Positive |
| 02/10/2020 | 37.26% | Cowen & Co. | $25 → $27 | Maintains | Market Perform |
| 01/14/2020 | — | Bernstein | Initiates Coverage On | → Market Perform | |
| 01/09/2020 | 27.1% | Wells Fargo | $24 → $25 | Maintains | Equal-Weight |
| 12/10/2019 | 42.35% | Citigroup | $27 → $28 | Maintains | Buy |
| 10/30/2019 | 67.77% | Goldman Sachs | $29 → $33 | Upgrades | Neutral → Buy |
| 10/08/2019 | 27.1% | Morgan Stanley | $28 → $25 | Maintains | Equal-Weight |
| 10/01/2019 | 37.26% | Citigroup | $28 → $27 | Maintains | Buy |
| 09/12/2019 | 22.01% | Wells Fargo | $22 → $24 | Maintains | Market Perform |
| 09/05/2019 | 27.1% | Jefferies | $23 → $25 | Upgrades | Hold → Buy |
| 08/29/2019 | — | Johnson Rice | Upgrades | Hold → Buy | |
| 08/12/2019 | 27.1% | Susquehanna | → $25 | Upgrades | Neutral → Positive |
| 07/31/2019 | 72.85% | Raymond James | $32 → $34 | Maintains | Outperform |
| 07/31/2019 | — | Seaport Global | Upgrades | Sell → Neutral | |
| 07/31/2019 | 42.35% | Citigroup | $23 → $28 | Upgrades | Neutral → Buy |
| 07/15/2019 | — | Johnson Rice | Downgrades | Buy → Hold | |
| 04/30/2019 | 57.6% | Citigroup | $29 → $31 | Maintains | Neutral |
| 04/15/2019 | 77.94% | Raymond James | $40 → $35 | Maintains | Outperform |
| 04/15/2019 | 42.35% | Barclays | $32 → $28 | Maintains | Equal-Weight |
| 03/11/2019 | 67.77% | Goldman Sachs | → $33 | Initiates Coverage On | → Neutral |
| 01/10/2019 | 77.94% | Stephens & Co. | → $35 | Initiates Coverage On | → Overweight |
| 01/04/2019 | 47.43% | Citigroup | $31 → $29 | Maintains | Neutral |
What is the target price for NOV (NOV)?
The latest price target for NOV (NYSE: NOV) was reported by RBC Capital on October 30, 2023. The analyst firm set a price target for $24.00 expecting NOV to rise to within 12 months (a possible 22.01% upside). 32 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for NOV (NOV)?
The latest analyst rating for NOV (NYSE: NOV) was provided by RBC Capital, and NOV maintained their sector perform rating.
When is the next analyst rating going to be posted or updated for NOV (NOV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NOV, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NOV was filed on October 30, 2023 so you should expect the next rating to be made available sometime around October 30, 2024.
Is the Analyst Rating NOV (NOV) correct?
While ratings are subjective and will change, the latest NOV (NOV) rating was a maintained with a price target of $23.00 to $24.00. The current price NOV (NOV) is trading at is $19.67, which is out of the analyst's predicted range.